Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Hypertension. 2021 Jun 28;78(2):525–531. doi: 10.1161/HYPERTENSIONAHA.119.14483

Figure 2.

Figure 2.

Association between supine norepinephrine (NE) levels and standing systolic blood pressure (SBP, panel A) and diastolic blood pressure (DBP, panel B) after atomoxetine.